Edinburgh Molecular Imaging is a clinical phase biotechnology company focused on enabling image guided interventional medicine. The company´s molecular targetting technology has the potential to tackle disease in real-time to allow interventional procedures including surgery and therapy, providing more accurate treatment while sparing healthy tissue.